保健食品和食品
Search documents
东阿阿胶荣获金牛“最具投资价值奖” 董秘丁红岩荣获“金牛董秘奖”
Zhong Zheng Wang· 2025-11-01 07:24
Core Viewpoint - The 2024 Most Investment Value Award was awarded to Dong'e Ejiao, highlighting its recognition in the market for its investment potential [1][4]. Group 1: Awards and Recognition - The 2025 Forum for High-Quality Development of Listed Companies and the 27th Golden Bull Award Ceremony took place in Nantong, Jiangsu [1]. - Dong'e Ejiao's Secretary, Ding Hongyan, received the 2024 Golden Bull Secretary Award [1]. Group 2: Company Overview - Dong'e Ejiao is a leading producer of Ejiao and related products, operating under the state-owned China Resources Group [4]. - The company engages in the research, production, and sales of Ejiao, traditional Chinese medicine, health foods, and other products, exporting to over 10 countries and regions including Southeast Asia and Europe [4]. - Dong'e Ejiao has established itself as a national high-tech enterprise and has been involved in the formulation of national standards for gelatin-based traditional Chinese medicine [4]. Group 3: Award Criteria - The Golden Bull Award includes categories such as "Most Investment Value Award" and "Golden Bull Outstanding Entrepreneur Award," with a total of nine awards [5]. - The "Most Investment Value Award" evaluates companies based on 18 key indicators across six dimensions, including scale, profitability, debt repayment ability, asset management, growth, and innovation [5].